Hylenex recombinant human hyaluronidase PH20
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hylenex recombinant human hyaluronidase PH20, covering 2014-08-18 to 2014-08-18. Get the full timeline:
Most recent: Clinical Trial Update: Liquid Meal Study With Insulin Lispro With/Without Recombinant Human Hyaluronidase PH20 (rHuPH20) and Regular Human Insulin With rHuPH20 to Compare Pharmacokinetics, Postprandial Glycemic Response, and Optimal Insulin Dose in Participants With Type 2 Diabetes Mellitus (T2DM) [Phase 2]